• Teal S Hallstrand, Jonathan P Parsons, John G Mastronarde, David A Kaminsky, Kenneth W Rundell, James H Hull, William W Storms, John M Weiler, Fern M Cheek, Kevin C Wilson, Sandra D Anderson, and American Thoracic Society Subcommittee on Exercise-induced Bronchoconstriction.
• Am. J. Respir. Crit. Care Med.. 2013 May 1;187(9):1016-27.

BackgroundExercise-induced bronchoconstriction (EIB) describes acute airway narrowing that occurs as a result of exercise. EIB occurs in a substantial proportion of patients with asthma, but may also occur in individuals without known asthma.MethodsTo provide clinicians with practical guidance, a multidisciplinary panel of stakeholders was convened to review the pathogenesis of EIB and to develop evidence-based guidelines for the diagnosis and treatment of EIB. The evidence was appraised and recommendations were formulated using the Grading of Recommendations, Assessment, Development, and Evaluation approach.ResultsRecommendations for the treatment of EIB were developed. The quality of evidence supporting the recommendations was variable, ranging from low to high. A strong recommendation was made for using a short-acting β(2)-agonist before exercise in all patients with EIB. For patients who continue to have symptoms of EIB despite the administration of a short-acting β(2)-agonist before exercise, strong recommendations were made for a daily inhaled corticosteroid, a daily leukotriene receptor antagonist, or a mast cell stabilizing agent before exercise.ConclusionsThe recommendations in this Guideline reflect the currently available evidence. New clinical research data will necessitate a revision and update in the future.

15 keywords...

hide…